Advances in unraveling the pathogenesis of cartilage calcification{lozenge, open}{lozenge, open}Pour citer cet article, utiliser ce titre en anglais et sa référence dans le même volume de Joint Bone Spine.;Avancées pathogéniques des mécanismes de calcification du cartilage

Revue du Rhumatisme (Edition Francaise)

Volumn 74, Issue 2, 2007, Pages 168-172

  Ea, Hang Korng ^a  

^a CENTRE VIGGO PETERSEN   (France)

Author keywords

ANK; Apoptosis; Calcification; Matrix vesicles; Pyrophosphate

Indexed keywords

EID: 33847179804     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rhum.2006.12.001     Document Type: Short Survey

References (50)

1. Giachelli C.M. Vascular calcification mechanisms. J. Am. Soc. Nephrol. 15 (2004) 2959-2964
2. Giachelli C.M., Jono S., Shioi A., Nishizawa Y., Mori K., and Morii H. Vascular calcification and inorganic phosphate. Am. J. Kidney Dis. 4 Suppl 1 (2001) S34-S37
3. Rutsch F., and Terkeltaub R. Parallels between arterial and cartilage calcification: what understanding artery calcification can teach us about chondrocalcinosis. Curr. Opin. Rheumatol. 15 (2003) 302-310
4. Anderson H.C. Matrix vesicles and calcification. Curr. Rheumatol. Rep. 5 (2003) 222-226
5. Kirsch T., Swoboda B., and Nah H. Activation of annexin II and V expression, terminal differentiation, mineralization and apoptosis in human osteoarthritic cartilage. Osteoarthritis Cartilage 8 (2000) 294-302
6. Wang W., Xu J., and Kirsch T. Annexin V and terminal differentiation of growth plate chondrocytes. Exp. Cell Res. 305 (2005) 156-165
7. Hashimoto S., Ochs R.L., Rosen F., Quach J., McCabe G., Solan J., et al. Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc. Natl. Acad. Sci. USA 95 (1998) 3094-3099
8. Kirsch T., Wang W., and Pfander D. Functional differences between growth plate apoptotic bodies and matrix vesicles. J. Bone Miner. Res. 18 (2003) 1872-1881
9. Kirsch T. Annexins -their role in cartilage mineralization. Front. Biosci. 10 (2005) 576-581
10. Anderson H.C. Molecular biology of matrix vesicles. Clin. Orthop. Relat. Res. 314 (1995) 266-280
11. Kirsch T., and Wuthier R.E. Stimulation of calcification of growth plate cartilage matrix vesicles by binding to type II and X collagens. J. Biol. Chem. 269 (1994) 11462-11469
12. Kirsch T., Harrison G., Golub E.E., and Nah H.D. The roles of annexins and types II and X collagen in matrix vesicle-mediated mineralization of growth plate cartilage. J. Biol. Chem. 275 (2000) 35577-35583
13. Balmain N., Hotton D., Cuisinier-Gleizes P., and Mathieu H. Immunoreactive calbindin-D9K localization in matrix vesicle-initiated calcification in rat epiphyseal cartilage: an immunoelectron microscope study. J. Bone Miner. Res. 4 (1989) 565-575
14. Balmain N. Identification of calbindin-D9k in matrix vesicles. Bone Miner. 17 (1992) 197-201
15. 2+ signalling to membrane dynamics. Nat. Rev. Mol. Cell Biol. 6 (2005) 449-461
16. Arispe N., Rojas E., Genge B.R., Wu L.N., and Wuthier R.E. Similarity in calcium channel activity of annexin V and matrix vesicles in planar lipid bilayers. Biophys. J. 71 (1996) 1764-1775
17. Montessuit C., Caverzasio J., and Bonjour J.P. Characterization of a Pi transport system in cartilage matrix vesicles. Potential role in the calcification process. J. Biol. Chem. 266 (1991) 17791-17797
18. Montessuit C., Bonjour J.P., and Caverzasio J. Expression and regulation of Na-dependent Pi transport in matrix vesicles produced by osteoblast-like cells. J. Bone Miner. Res. 10 (1995) 625-631
19. Murshed M., Harmey D., Millan J.L., McKee M.D., and Karsenty G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev. 19 (2005) 1093-1104
20. Chen C.C., and Boskey A.L. Mechanisms of proteoglycan inhibition of hydroxyapatite growth. Calcif. Tissue Int. 37 (1985) 395-400
21. Chen C.C., Boskey A.L., and Rosenberg L.C. The inhibitory effect of cartilage proteoglycans on hydroxyapatite growth. Calcif. Tissue Int. 36 (1984) 285-290
22. Luo G., Ducy P., McKee M.D., Pinero G.J., Loyer E., Behringer R.R., et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386 (1997) 78-81
23. Terkeltaub R.A. Inorganic pyrophosphate generation and disposition in pathophysiology. Am. J. Physiol. Cell Physiol. 281 (2001) C1-C11
24. Johnson K., Hashimoto S., Lotz M., Pritzker K., Goding J., and Terkeltaub R. Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification. Arthritis Rheum. 44 (2001) 1071-1081
25. Lotz M., Rosen F., McCabe G., Quach J., Blanco F., Dudler J., et al. Interleukin 1 beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes. Proc. Natl. Acad. Sci. USA 92 (1995) 10364-10368
26. Johnson K., Moffa A., Chen Y., Pritzker K., Goding J., and Terkeltaub R. Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells. J. Bone Miner. Res. 14 (1999) 883-892
27. Miao D., and Scutt A. Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage. J. Histochem. Cytochem. 50 (2002) 333-340
28. Rees J.A., and Ali S.Y. Ultrastructural localisation of alkaline phosphatase activity in osteoarthritic human articular cartilage. Ann. Rheum. Dis. 47 (1988) 747-753
29. Harada M., Udagawa N., Fukasawa K., Hiraoka B.Y., and Mogi M. Inorganic pyrophosphatase activity of purified bovine pulp alkaline phosphatase at physiological pH. J. Dent. Res. 65 (1986) 125-127
30. Ho A.M., Johnson M.D., and Kingsley D.M. Role of the mouse ank gene in control of tissue calcification and arthritis. Science 289 (2000) 265-270
31. Okawa A., Nakamura I., Goto S., Moriya H., Nakamura Y., and Ikegawa S. Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat. Genet. 19 (1998) 271-273
32. Hessle L., Johnson K.A., Anderson H.C., Narisawa S., Sali A., Goding J.W., et al. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc. Natl. Acad. Sci. USA 99 (2002) 9445-9449
33. Nurnberg P., Thiele H., Chandler D., Hohne W., Cunningham M.L., Ritter H., et al. Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. Nat. Genet. 28 (2001) 37-41
34. Reichenberger E., Tiziani V., Watanabe S., Park L., Ueki Y., Santanna C., et al. Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am. J. Hum. Genet. 68 (2001) 1321-1326
35. Rutsch F., Schauerte P., Kalhoff H., Petrarulo M., August C., and Diekmann L. Low levels of urinary inorganic pyrophosphate indicating systemic pyrophosphate deficiency in a boy with idiopathic infantile arterial calcification. Acta Paediatr. 89 (2000) 1265-1269
36. Rutsch F., Vaingankar S., Johnson K., Goldfine I., Maddux B., Schauerte P., et al. PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. Am. J. Pathol. 158 (2001) 543-554
37. Rutsch F., Ruf N., Vaingankar S., Toliat M.R., Suk A., Hohne W., et al. Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification. Nat. Genet. 34 (2003) 379-381
38. Zaka R., and Williams C.J. Genetics of chondrocalcinosis. Osteoarthritis Cartilage 13 (2005) 745-750
39. Zaka R., Stokes D., Dion A.S., Kusnierz A., Han F., and Williams C.J. P5L mutation in Ank results in an increase in extracellular inorganic pyrophosphate during proliferation and nonmineralizing hypertrophy in stably transduced ATDC5 cells. Arthritis Res. Ther. 8 (2006) R164
40. Pendleton A., Johnson M.D., Hughes A., Gurley K.A., Ho A.M., Doherty M., et al. Mutations in ANKH cause chondrocalcinosis. Am. J. Hum. Genet. 71 (2002) 933-940
41. Williams C.J., Zhang Y., Timms A., Bonavita G., Caeiro F., Broxholme J., et al. Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH. Am. J. Hum. Genet. 71 (2002) 985-991
42. Williams C.J., Pendleton A., Bonavita G., Reginato A.J., Hughes A.E., Peariso S., et al. Mutations in the amino terminus of ANKH in two US families with calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum. 48 (2003) 2627-2631
43. Hirose J., Ryan L.M., and Masuda I. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum. 46 (2002) 3218-3229
44. Ryan L.M., and Rosenthal A.K. Metabolism of extracellular pyrophosphate. Curr. Opin. Rheumatol. 15 (2003) 311-314
45. Fedde K.N., Blair L., Silverstein J., Coburn S.P., Ryan L.M., Weinstein R.S., et al. Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J. Bone Miner. Res. 14 (1999) 2015-2026
46. Harmey D., Hessle L., Narisawa S., Johnson K.A., Terkeltaub R., and Millan J.L. Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am. J. Pathol. 164 (2004) 1199-1209
47. Rosenthal A.K., and Ryan L.M. Ageing increases growth factor-induced inorganic pyrophosphate elaboration by articular cartilage. Mech. Ageing Dev. 75 (1994) 35-44
48. Rosen F., McCabe G., Quach J., Solan J., Terkeltaub R., Seegmiller J.E., et al. Differential effects of aging on human chondrocyte responses to transforming growth factor beta: increased pyrophosphate production and decreased cell proliferation. Arthritis Rheum. 40 (1997) 1275-1281
49. Rosenthal A.K., Derfus B.A., and Henry L.A. Transglutaminase activity in aging articular chondrocytes and articular cartilage vesicles. Arthritis Rheum. 40 (1997) 966-970
50. Hirose J., Masuda I., and Ryan L.M. Expression of cartilage intermediate layer protein/nucleotide pyrophosphohydrolase parallels the production of extracellular inorganic pyrophosphate in response to growth factors and with aging. Arthritis Rheum. 43 (2000) 2703-2711